Evidence map›Paper›PMID 40764347›Full record

ArticleScientific reports2025

Assessment of the in vitro antimicrobial activity and fatty acid composition of crocodile oil from Crocodylus siamensis.

Duygu Kirkik, Fatih Hacimustafaoğlu, Cemre Özkanca, Sevgi Kalkanli Taş, Mahfuz Elmastaş

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Duygu KirkikDepartment of Immunology, Hamidiye Medicine Faculty, University of Health Sciences, Istanbul, Türkiye. dygkirkik@gmail.com.ORCID http://orcid.org/0000-0003-1417-6915
Fatih HacimustafaoğluMedical Laboratory Techniques Program, University of Health Sciences, Istanbul, Türkiye.ORCID http://orcid.org/0000-0002-1429-0526
Cemre ÖzkancaPharmacy Services Program, University of Health Sciences, Istanbul, Türkiye.ORCID http://orcid.org/0000-0002-0342-2060
Sevgi Kalkanli TaşDepartment of Immunology, Hamidiye Medicine Faculty, University of Health Sciences, Istanbul, Türkiye.ORCID http://orcid.org/0000-0001-5288-6040
Mahfuz ElmastaşDepartment of Basic Pharmaceutical Sciences, Faculty of Pharmacy, University of Health Sciences, Istanbul, Türkiye.ORCID http://orcid.org/0000-0002-1502-1141

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Crocodile oil has been traditionally used for its medicinal properties, including wound healing and antimicrobial effects. However, scientific validation of its antimicrobial activity remains limited. Although its potential to induce microbial resistance and its safety profile have been proposed in previous literature, these aspects were not addressed experimentally in the current study. This study aimed solely to evaluate the in vitro antimicrobial activity of crocodile oil using dip solution and standard microbiological approaches. Standard bacterial and fungal strains, including Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa, and Candida albicans, were tested using disk diffusion and minimum inhibitory concentration (MIC) methods. Fatty acid composition was analyzed using GC-FID. The results demonstrated significant antimicrobial activity against Staphylococcus aureus ATCC 29213, Staphylococcus aureus ATCC 43300 (methicillin-resistant), Enterococcus faecalis, Escherichia coli, Pseudomonas aeruginosa, and Candida albicans. No inhibition was observed against Staphylococcus epidermidis ATCC 12228 and Klebsiella pneumoniae ATCC 4352, as confirmed by both disk diffusion and MIC methods. MIC values ranged from 187.5 to 500 µL/Ml. The lowest MIC was observed for Escherichia coli (187.5 µL/mL), while MICs of 375 µL/mL were recorded for Staphylococcus aureus ATCC 43300, Enterococcus faecalis, Pseudomonas aeruginosa, and Candida albicans. The highest MIC (500 µL/mL) was observed for Staphylococcus aureus ATCC 29213. While the results are promising, further studies are necessary to evaluate safety, resistance development potential, and in vivo efficacy.

Indexed as

Alligators and CrocodilesAnti-Infective AgentsFatty AcidsOilsAnimalsBacteriaCandida albicansEscherichia coliMicrobial Sensitivity TestsPseudomonas aeruginosaStaphylococcus aureusAnti-Infective AgentsFatty AcidsOilsAlternative therapyAntimicrobial activityBacterial inhibitionCrocodile oilTraditional medicine

Identifiers

PMID40764347
PMCPMC12325730

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.